Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-Alfatide II PET/CT in Cancer Diagnostics
NCT02441972Phase 1Unknown
- Sponsor
- The Affiliated Hospital of Jiangnan University
- Start
- Jan 2012
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 18f-alfatide in bronchogenic carcinoma, breast carcinoma, head and neck cancer (HNC) and 1 more, sponsored by The Affiliated Hospital of Jiangnan University. Primary endpoint: Safety data including vital signs at 1 day. Status: unknown.
02
Drugs
18f-alfatide
03
Conditions
bronchogenic carcinomabreast carcinomahead and neck cancer (HNC)lymphoma
Beyond the preview
Go deeper on NCT02441972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02441972.